Conversely, in patients with rheumatic diseases, the serum ADA concentration range associated with clinical response is considerably lower, 2–8 μg/mL in RA 2.5–8.0 μg/mL in SpA, and 1–8 μg/mL in PsA [14,84,105]. Here, ADA is linked to rheumatoid arthritis.